ScienceBlog

BioSTARTM device achieves 90 percent closure rate for atrial septal defect in children

A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect ...
Yahoo Finance

Occlutech(R) Announces FDA Approval of its Occlutech(R) ASD Occluder and Occlutech(R) Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial ...

An ASD can be closed by a minimally invasive procedure. A catheter is inserted via a blood vessel in the groin and guided to the heart. The Occlutech ASD Occluder is a self-expanding Nitinol double ...
TCTMD

TCT 691: Percutaneous Closure of Left Atrial Appendage With Suture Dehiscence Using ASD Closure Device Guided by a Novel Live 3D-ICE Probe

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication! Receive the the latest news, research, and presentations from major meetings ...
Yahoo Finance

Occlutech(R) Announces Commercial Cases of Occlutech ASD Occluder Device Implantation in the U.S.

Occlutech, a world leading specialist provider of minimally invasive structural heart devices and their exclusive United States (U.S.) distributor, B. Braun Interventional Systems Inc. (BIS) today ...
TCTMD

TCT 1300: Double Atrial Septal Defect of Challenging Sizing: Closure With a Single Device Under Multi-Modality Imaging Guidance (3D-ICE and Micro-TEE)

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...